Form 4: Sabra Health Care Director Acquires Stock Units

Sentiment:

Insider Transaction Report


Sabra Health Care REIT Director Catherine Cusack acquired 781 common stock units through dividend equivalent payments, increasing her beneficial ownership to 72,929 units.

Summary

  • Catherine Cusack, a Director of Sabra Health Care REIT, Inc. (SBRA), acquired 781 common stock units.
  • The acquisition occurred on February 27, 2026, and was made at a price of $0 per unit.
  • These units represent dividend equivalent payments on previously granted stock units under the Issuer's 2009 Performance Incentive Plan.
  • The acquired units will vest and become payable on the same terms as the original stock units to which they relate.
  • Following this transaction, Catherine Cusack beneficially owns a total of 72,929 common stock units.
  • This total includes 2,854 unvested stock units and 51,345 stock units that have vested but payment has been deferred.
  • Each stock unit represents the right to receive one share of Sabra Health Care REIT, Inc. Common Stock.
  • The transaction was made pursuant to a Rule 10b5-1(c) plan.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a moderately positive signal, indicating continued director alignment through equity compensation, though not a direct open-market purchase. It's a routine event that increases insider ownership.

Positives

  • A Director's beneficial ownership of company equity has increased, which generally signals continued alignment of interests with shareholders.
  • The transaction was executed under a Rule 10b5-1 plan, indicating a pre-arranged, systematic approach to equity compensation.

Negatives

  • The acquisition was through dividend equivalent payments, not an open-market purchase, which typically provides a stronger signal of management's direct investment conviction.

Future Outlook

This filing does not contain forward-looking statements or guidance regarding the company's future financial performance or strategic outlook.

Industry Context

StockSavvy.ai notes that insider transactions, such as the acquisition of stock units through dividend equivalents, are a common component of executive and director compensation packages in the REIT sector. While not an open-market purchase, it reflects the ongoing accumulation of equity by a key insider, which can be viewed as a positive for long-term alignment with shareholder interests.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Policy AdherenceThe transaction was made pursuant to a contract, instruction, or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).02/27/2026Indicates adherence to pre-planned trading arrangements, reducing concerns about opportunistic insider trading.

Stakeholder Impact

  • Shareholders: Increased director ownership through equity compensation can enhance alignment between management and shareholder interests, potentially fostering more shareholder-friendly decision-making.

Next Steps

  • The acquired stock units will vest and become payable on the same terms as the original stock units to which they relate.

Key Dates

DateDescription
02/27/2026Date of transaction where 781 common stock units were acquired.
03/03/2026Date the Statement of Changes in Beneficial Ownership (Form 4) was signed.

Recommendation

hold

The acquisition of stock units through dividend equivalents by a director is a routine compensation event and does not provide a strong signal for a change in investment recommendation. It primarily reflects ongoing alignment of interests rather than a new, significant investment decision based on material non-public information.

Keywords

Sabra Health Care REIT, SBRA, Form 4, Insider Transaction, Director, Stock Units, Dividend Equivalent, Equity Compensation, Corporate Governance

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.